Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Other solid neoplasm 1Endocrine 1Dermatologic 1

Conditions

Solid Tumors 11Mesothelioma, Malignant 8Solid Tumor 6Advanced Solid Tumor 6Mesothelioma 3Melanoma 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3Treatment-Refractory Solid Tumors 2Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Merkel Cell 2Wilms Tumor 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Stomach Neoplasms 1Solid Tumour 1Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Select Advanced Solid Tumors 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Solid Tumors 1Locally Advanced Solid Tumor 1Kidney Neoplasms 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Gastrointestinal Neoplasms 1

Interventions

pembrolizumab 1atezolizumab 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy 1Immunoglobulin G 1Drug Therapy 1Disulfides 1Biological Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Carcinoma × atezolizumab × Other solid neoplasm × Clear all
NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
133 enrolled
DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡